21 related articles for article (PubMed ID: 3564852)
1. The Role of Ferric Nitrilotriacetate in Renal Carcinogenesis and Cell Death: From Animal Models to Clinical Implications.
Okazaki Y
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326646
[TBL] [Abstract][Full Text] [Related]
2. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis.
Awai M; Narasaki M; Yamanoi Y; Seno S
Am J Pathol; 1979 Jun; 95(3):663-73. PubMed ID: 377994
[TBL] [Abstract][Full Text] [Related]
3. [Ferric nitrilotriacetate (Fe3+-NTA) produces active oxygens and induces malignant transformation on cultured rat liver cells].
Awai M
Tanpakushitsu Kakusan Koso; 1988 Dec; 33(16):2844-54. PubMed ID: 2855152
[No Abstract] [Full Text] [Related]
4. Renal impairment in experimental hemochromatosis in rats.
May ME; May EE; Parmley RT; Spicer SS; Buse MG
Horm Metab Res; 1983 Apr; 15(4):194-6. PubMed ID: 6862358
[TBL] [Abstract][Full Text] [Related]
5. Chronic liver iron overload in the baboon by ferric nitrilotriacetate. Morphologic and functional changes with special reference to collagen synthesis enzymes.
Brissot P; Farjanel J; Bourel D; Campion JP; Guillouzo A; Rattner A; Deugnier Y; Desvergne B; Ferrand B; Simon M
Dig Dis Sci; 1987 Jun; 32(6):620-7. PubMed ID: 3568950
[TBL] [Abstract][Full Text] [Related]
6. Experimental iron overload. Ultrastructural studies.
Iancu TC; Shiloh H
Ann N Y Acad Sci; 1988; 526():164-78. PubMed ID: 3291681
[No Abstract] [Full Text] [Related]
7. [Experimental models of iron overload].
Danĕk PF
Cesk Fysiol; 1988; 37(5):425-34. PubMed ID: 3060274
[No Abstract] [Full Text] [Related]
8. Experimental iron overload using ferric nitrilotriacetate (Fe3+-NTA): a proposal model of the diseases in man caused by iron overload.
Awai M
Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1650-9. PubMed ID: 3564852
[No Abstract] [Full Text] [Related]
9. [Pathogenesis and mechanism of iron overload: ferric nitrilotriacetate, hemosiderin, active oxygen, and carcinogenesis].
Awai M
Rinsho Ketsueki; 1989 Aug; 30(8):1115-27. PubMed ID: 2689676
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
